Malignant Lymphoma: Nomenclature, Recently Recognized Subtypes, and Current Concepts

References

• Willis R: Pathology of Tumours. Butterworths, London 1948, pp 760–783
   Google Scholar
• Rappaport H: Tumours of the haemopoietic system. InAtlas of Tumour Pathology, Section 3, Fascicle 8. US Armed Forces Institute of Pathology, Washington, DC, 1966
   Google Scholar
• Lukes RI, Collins RD: Immunological characterisation of human malignant lymphomas. Cancer 34:1488–1503, 1974
   PubMed Web of Science ®Google Scholar
• Gerard-Marchant R, Hamlin I, Lennert K: Classification of non-Hodgkin's lymphoma. Lancet 2:406–408, 1974
   Web of Science ®Google Scholar
• Dorfman RF: Classification of non-Hodgkin's lymphoma. Lancet 1: 1295, 1974
   Google Scholar
• Bennett MH, Farrer-Brown G, Henry K: Classification of non-Hodgkin's lymphoma. Lancet 2:405–406, 1974
   Web of Science ®Google Scholar
• Mathe G, Rappaport H, O'Connor GT: Histological and cyto-logical typing of neoplastic diseases of haemopoietic and lymphoid tissues. In World Health Organization International Histological Classification of Tumors, No 14. World Health Organization, Geneva, 1976
   Google Scholar
• Barcos MP, Lukes RI: Malignant lymphoma of convoluted lymphocytes. A new entity of pos sible T-cell type, In Conflicts in Childhood Cancer. An Evaluation of Current Management, L Sinks, JO Godden (eds). Allen R Liss Inc, New York, 1975, pp 147–178
   Google Scholar
• Collins RD, Waldron JA, Glick AD: Results of multiparameter studies of T cell lymphoid neoplasms . AmJ Clin Pathol 72: 699–701, 1979
   PubMed Web of Science ®Google Scholar
• Hanna MG: An autoradiographic study of the germinal centre in spleen white pulp during early intervals of the immune response. Lab Invest 13:95–105,1964
   PubMed Web of Science ®Google Scholar
• Koburg E: Cell population and cell migration in the tonsil. In Germinal Centres in Immune Responses, Cottier H, Odart-chenko N, Schindler R, Congdon CC (eds). Springer Verlag, Berlin, 1967, pp 176–182
   Google Scholar
• Hsu SM, Jaffe ES: Phenotypic expression of B lymphocytes. Immunoglobulin expression of germinal centre cells. Am J Pathol 114:396–405, 1984
   PubMed Web of Science ®Google Scholar
• The Non-Hodgkin’s Lymphoma Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphoma. Summary and description of a Working Formulation for clinical usage. Cancer 49:2112–2135, 1982
   PubMed Web of Science ®Google Scholar
• Pangalis GA, Nathwani BN, Rappaport H: Malignant lym-phoma, well differentiated lymphocytic. Its relationship with chronic lymphocytic leukaemia and macroglobulinemia of Waldenström. Cancer 39:999–1010, 1977
   PubMed Web of Science ®Google Scholar
• Lennert K: Histopathology of Non-Hodgkin's Lymphoma (Based on the Kiel Classification). Springer Verlag, Berlin, 1981
   Google Scholar
• Leong AS-Y: A critique of some contemporary classifications of non-Hodgkin's lymphoma. Which one should we now use? Pathology 15:437–442, 1983
   PubMed Web of Science ®Google Scholar
• Chen MG, Prosnitz LR, Gonzalez-Serva A: Results of radiotherapy in stage I and H non-Hodgkin's lymphoma. Cancer 43:1245–1251, 1979
   PubMed Web of Science ®Google Scholar
• Gospodarowicz MK, Bush RS, Brown TC: Prognostic factors in nodular lymphomas: A multivaried analysis based on the Princess Margaret Hospital experience. Int J Rad Oncol Biol Phy 10:49–496, 1984
   Google Scholar
• Manfardini S, Banfi A, Bonadonna G: Improved 5 year survival after combined radiotherapy-chemotherapy for stage 1-2 non-Hodgkin's lymphoma. Int J Rad Oncol Biol Phy 6:125–131, 1980
   PubMed Web of Science ®Google Scholar
• Horning SJ, Rosenberg SA: The natural history of initially untreated low-grade non-Hodgkin's lymphomas. N Engl J Med 311:1471–1478, 1984
   PubMed Web of Science ®Google Scholar
• Lister TA, Cullen MH, Beard MEJ: Comparison of combined and single agent chemotherapy in non-Hodgkin's lym-phoma or favourable histologic type. Br Med J 1:533–536, 1978
   PubMed Web of Science ®Google Scholar
• Anderson KC, Skarrin AT, Rosenthal DS: Combination chemotherapy for advanced non-Hodgkin's lymphomas other than diffuse histiocytic or undifferentiated histologies. Cancer Treat Rpt 68:1343–1349, 1984
   PubMedGoogle Scholar
• Young RC, LCmgo DL, Glatstein E: The treatment of indolent lymphomas: Watchful waiting versus aggressive combined modality treatment. Sem Haematol 25:11–23, 1988
   PubMed Web of Science ®Google Scholar
• Peterson SA, Anderson JR, Frizzera DC: Combination chemotherapy prolongs survival in follicular mixed lymphoma (FML). Blood 9:259a, 1990
   Google Scholar
• DeVita VT, Chabner B, Hubbard SM, et al: Advanced diffuse histiocytic lymphoma, a potentially curable disease. Lancet 1:248, 1973
   Web of Science ®Google Scholar
• Canellos GP, Skarin AT, Klatt MM: m-BACOD combination chemotherapy regimen in the treatment of diffuse large cell lymphoma. Sem Haematol 24\(Supp11):2–18, 1987
   PubMedGoogle Scholar
• Coiffier B, Byron P-A, Berger F: Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (protocol LNH-80). J Clin Oncol 4:147–158, 1986
   PubMed Web of Science ®Google Scholar
• Coleman M, Gerstein G, Topilow A: Advances in chemotherapy for large cell lymphoma. Sem Haematol24:(Supp11): 8–20, 1987
   PubMedGoogle Scholar
• Klimo P, Connors JM: MACOP-B chemotherapy for the treatment of diffuse large cell lymphoma. Ann Int Med 102: 596–604, 1985
   PubMed Web of Science ®Google Scholar
• Wollner N, Wachtel AE, Exelby PR: Improved prognosis in children with intra-abdominal non-Hodgkin's lymphoma following LSA2L2 protocol chemotherapy. Cancer 45:3034–3039, 1980
   PubMed Web of Science ®Google Scholar
• Levine AM, Forman SJ, Meyer PR: Successful therapy of convoluted T lymphoblastic lymphoma in adults. Blood 61: 92–96, 1983
   PubMed Web of Science ®Google Scholar
• Miller RA, Maloney DG, Warnke R, Levy R: Treatment of B-cell lymphoma with monoclonal antüdiotype antibody. N Eng J Med 306:517–522, 1982
   PubMed Web of Science ®Google Scholar
• Horning SJ, Merigan TC, Krown S: Human interferon a in malignant lymphoma and Hodgkin's disease. Results of the American Cancer Society Trial. Cancer 56:1305–1310, 1985
   PubMed Web of Science ®Google Scholar
• Stein H, Mason DY, Gerdes J: The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66:848–858, 1985
   PubMed Web of Science ®Google Scholar
• Pallesen G: The diagnostic significance of the CD 30 (Ki-1) antigen. Histopathology 16:409–413, 1990
   PubMed Web of Science ®Google Scholar
• Pins M, Brown DC, Gatter KC, Mason DY: CD 30 expression in non-Hodgkin's lymphoma. Histopathology 17:211–218, 1990
   PubMed Web of Science ®Google Scholar
• Leoncini L, Del Vecchio MT, Kraft R et al: Hodgkin's disease and CD 30-positive anaplastic large cell lymphomas— a continuous spectrum of malignant disorders. A quantitative and immunohistologic study. Am J Pathol 137:1047–1057, 1990
   PubMed Web of Science ®Google Scholar
• Kadin ME, Nasu K, Sako D: Lymphomatoid papulosis, a cutaneous proliferation of activated helper T-cells expressing Hodgkin's disease-associated antigens. Am J Pathol 119: 315–325, 1985
   PubMed Web of Science ®Google Scholar
• Kaudewitz P, Stein H, Dallenbach F: Primary and secondary cutaneous Ki-1 + (CD 30+) anaplastic large cell lymphomas. Morphologic, immunohistologic, and clinical characteristics. Am J Pathol 135:359–367, 1989
   PubMed Web of Science ®Google Scholar
• Kadin ME, Sako D, Berliner N: Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy. Blood 68:1042–1049, 1986
   PubMed Web of Science ®Google Scholar
• Schnitzer B, Roth MS, Hyder DM, Ginsburg D: Ki-1 lymphomas in children. Cancer 61:1213–1221, 1988
   PubMed Web of Science ®Google Scholar
• Bitter MA, Franklin WA, Larson RA: Morphology in Ki-1 (CD 30) positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5)(p23;q35). Am J Pathol 14:305–316, 1990
   Web of Science ®Google Scholar
• Mason DY, Bastard C, Rimokh R: CD 30-positive large cell lymphomas (ICi-1 lymphoma) are associated with a chromosomal translocation involving 5q35. Br J Haematol 74:161–168, 1990
   PubMed Web of Science ®Google Scholar
• Beljaards RC, Meijer CJLM, Scheffer E: Prognostic significance of CD 30 (Ki- 1/BER H2) expression in primary cutaneous large cell lymphomas of T-cell origin. A clinico-pathologic and itrumunohistochemical study in 20 patients. Am J Pathol 135:1169–1178, 1989
   PubMed Web of Science ®Google Scholar
• Falini B, Pileri S, Stein H: Variable expression of leucocyte common (CD 45) antigen in CD 30 (Ki-1) positive anaplastic large cell lymphoma: Implications for the differential diagnosis between lymphoid and non-lymphoid malignancies. Hum Pathol 21:624–629, 1990
   PubMed Web of Science ®Google Scholar
• Delsol G, Alsaati T, Gatter KC: Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis. Am J Pathol 130:59–70, 1988
   PubMed Web of Science ®Google Scholar
• Lardelli P, Bookman MA, Sundeen J: Lymphocytic lymphoma of intermediate differentiation: Morphologic and Immunophenotypic spectrum and clinical correlations. Am J Surg Pathol 14:752–763, 1990 The Journal of Histotechnology/ Vol. 15, No. 3/September 1992
   PubMed Web of Science ®Google Scholar
• Close P, Lauder I: Mantle zone lymphoma—is it an entity? J Pathol 160:279–281, 1990
   PubMed Web of Science ®Google Scholar
• Medeiros U, Van Kriken JH, Jaffe ES: Association of BCL-1 rearrangements with lymphocytic lymphoma of intermediate differentiation. Blood 76:2086–2090, 1990
   PubMed Web of Science ®Google Scholar
• Rodriguez M, Pugh W, Ince C: Clinical and histologic characteristics of lymphomas with the translocation (11;14)(q13; q32) (abstract). Proc ASCO 1989
   Google Scholar
• Isaacson PG, Wright DH: Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer 52:1410–1416, 1983
   PubMed Web of Science ®Google Scholar
• Isaacson P, Wright DH: Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue. Cancer 53:2515–2524, 1984
   PubMed Web of Science ®Google Scholar
• Hyjek E, Smith WJ, Isaacson PG: Primary B-cell lymphoma of salivary glands and its relationship to myoepithelial sial-adenitis. Hum Pathol 19:766–776, 1988
   PubMed Web of Science ®Google Scholar
• Chan JKC, Ng CS, Isaacson PG: Relationship between high-grade lymphoma and low-grade B-cell mucosa-associated lymphoid tissue lymphoma (MALToma) of the stomach. Am J Pathol 136:1153–1164 1990
   PubMed Web of Science ®Google Scholar
• Isaacson PG, Price SK: Light chains in Mediterranean lym-phoma. J Clin Path 38:601–606, 1985
   PubMed Web of Science ®Google Scholar
• Cogliatti SB, Lennert K, Hansmann ML, Zwigers TL: Monocytoid B-cell lymphoma: Clinical and prognostic features of 21 patients. J Clin Path 43:619–625, 1990
   PubMed Web of Science ®Google Scholar
• Sheibani K, Burke JS, Swartz WG: Monocytoid B-cell lymphoma: Clinicopathologic study of 21 cases of a unique type of low-grade lymphoma. Cancer 62:1531–1538, 1988
   PubMed Web of Science ®Google Scholar
• Isaacson PG: Parafollicular B lymphocytes (letter). Am J Clin Pathol 88:393, 1987
   PubMed Web of Science ®Google Scholar
• Watanabe S, Shimosato Y, Shimoyama M. Lymphoma and leukaemia of T lymphocytes. Pathol Annu 6(part 2):155–203, 1981
   Google Scholar
• Stein H, Tolksdorf G, Lennert K: T cell lymphomas. A cell origin related classification on the basis of cytologic, immunologic and enzyme cytochemical criteria. Pathol Res Pract 171:197–215, 1981
   PubMed Web of Science ®Google Scholar
• Forbes IJ, Leong AS-Y: T-cell neoplasms of the peripheral compartment. In Essential Oncology of the Lymphocyte. London, Springer-Verlag, 1987, pp 309–337
   Google Scholar
• Suchi T, Lennert K, Tu L-Y, et al: Histopathology and immunohistochemistry of peripheral T cell lymphomas: A proposal for their classification. J Clin Pathol 40:995–1015, 1987
   PubMed Web of Science ®Google Scholar
• Stansfeld AG, Diebold J, Kapanci Y et al: Updated Kiel classification for_lympliomas. Lancet 1:292–293, 1988
   PubMed Web of Science ®Google Scholar
• Hastrup N, Hamilton-Dutoit S, Ralfkiaer E, Pallesen G: Peripheral T-cell lymphomas: An evaluation of reproducibility of the updated Kiel classification. Histopathology 18:99–105, 1991
   PubMed Web of Science ®Google Scholar
• Noorduyn LA, Van der Valk P, Van Heerde P: Stage is a better prognostic indicator than morphologic subtype in primary non-cutaneous T-cell lymphoma. Am J Clin Pathol 93:49–57, 1990
   PubMed Web of Science ®Google Scholar
• Armitage JO, Greer JP, Levine AM: Peripheral T-cell lymphoma. Cancer 63:158–163, 1989-
   Google Scholar
• Feller AC, Griesser GH, -Schilling CV et al: Clonal gene rearrangement patterns correlate with immunophenotype and clinical parameters in patients with angioimmunoblastic lymphadenopathy. Am J Pathol 133:549–556, 1988
   PubMed Web of Science ®Google Scholar
• De Rerhee RA, Weiland LH, McDonald TJ: Polymorphic reticulosis, lymphomatoid granulomatosis: Two diseases or one? Mayo Clin P roc 53:634–640, 1978
   PubMed Web of Science ®Google Scholar
• Jaffe ES. Angiocentric immunoproliferative lesions. In Surgical Pathology of the Lymph Nodes and Related Organs, Jaffe ER (ed). WB Saunders, Philadelphia, 1985, pp 241–246
   Google Scholar
• Muller-Hermelink HK, Steinman G, Stein H, Lennert K: Malignant lymphoma of plasmacytoid T-cells. Morphologic and immunologic studies characterising a special type of T-cell. Am J Surg Pathol 7:849–862, 1983
   PubMed Web of Science ®Google Scholar
• Prasthofer EF, Grizzle WE, Pachal JT, Grossi CE: Plas-macytoid T-cell lymphoma associated with chronic myelo-proliferative disorder. Am J Surg Pathol 9:380–387, 1985
   PubMedGoogle Scholar
• Beiske K, Langholm R, Godall T, Marton PF: T zone lym-phoma with predominance of "plasmacytoid T cells" as-sociated with myelomonocytic leukaemia— a distinct clinico-pathological entity. J Pathol 150:247–255,1986
   PubMed Web of Science ®Google Scholar
• Facchetti F, DeWolf-Peeters C, Kennes C: Leukaemia-associated lymph node infiltrates of plasmacytoid mono-cytes, so-called plasmacytoid T-cells. Evidence for two dis-tinct histological and irrununophenotypical patterns. Am J Surg Pathol 14:101–112, 1990
   PubMed Web of Science ®Google Scholar
• Koo CH, Mason DY, Miller R, Ben-Ezra J: Additional evidence that "plasmacytoid T-cells lymphoma" associated with chronic myeloproliferative disorders is of macrophage-monocyte origin. Am J Clin Pathol 93:822–827, 1990
   PubMed Web of Science ®Google Scholar
• Isaacson PG, O'Connor NTJ, Spencer J: Malignant histiocy-tosis of the intestine: A T-cell lymphoma. Lancet 2:688–690, 1985
   PubMed Web of Science ®Google Scholar
• Wilson MS, Weiss LM, Gatter KC: Malignant histiocytosis. A re-assessment of cases previously reported in 1975 based on paraffin section irrununotyping studies. Cancer 66:530–536, 1990
   PubMed Web of Science ®Google Scholar
• Weiss LM, Picker LJ, Copenhaver CM: Large cell hae-matolymphoid neoplasms of uncertain lineage. Hum Pathol 19:967–973, 1988
   PubMed Web of Science ®Google Scholar
• Jaffe ES, Costa J, Fauci AS: Malignant lymphoma and erythrophagocytosis simulating malignant histiocytosis. Am J Med 75:741–749, 1983
   PubMed Web of Science ®Google Scholar
• Kadin ME, Kamoun M, Lamberg J: Erythrophagocytic T gamma lymphoma: A clinicopathologic entity resembling malignant histiocytosis. N Engl J Med 304:648–653, 1981
   PubMed Web of Science ®Google Scholar
• Risdall RJ, McKenna RW, Nesbit ME: Virus associated hae-mophagocytic syndrome: A benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 44:993–1002, 1979
   PubMed Web of Science ®Google Scholar
• Ramsay AD, Smith WJ, Isaacson PG: T-cell rich B-cell lym-phoma. Am J Surg Pathol 12:433–443, 1988
   PubMed Web of Science ®Google Scholar
• Katzin WE, Linden MD, Fishleder AJ, Tubbs RR: Im-munophenotypic and genotypic characterisation of diffuse mixed non-Hodgkin's lymphomas. Am J Pathol 135:615–621, 1989
   PubMed Web of Science ®Google Scholar
• Thomson AD: The thymic origin of Hodgkin's disease. Can-cer 9:37–50, 1955
   PubMed Web of Science ®Google Scholar
• Marshall AHE, Wood C: The involvement of the thymus in Hodgkin's disease. J Pathol Bact 73:163–166, 1957
   Google Scholar
• Keller AR, Castleman B: Hodgkin's disease of the thymus gland. Cancer 33:1615–1623, 1974
   PubMed Web of Science ®Google Scholar
• Order SE, Hellman S: Pathogenesis of Hodgkin's disease. Lancet 1:571–573, 1972
   PubMed Web of Science ®Google Scholar
• DeVita VT: Lymphocyte reactivity in Hodgkin's disease: A lymphocyte civil war. N Engl J Med 289:801–802, 1973
   PubMed Web of Science ®Google Scholar
• Kadin ME, Stites DP, Levy R, Warnke R: Exogenous origin of immunoglobulin in Reed-Sternberg cells of Hodgkin's dis-ease. N Engl J Med 299:1208–1214, 1978
   PubMed Web of Science ®Google Scholar
• Poppema S, Elema JD, Halie MR: The significance of in-tracytoplasmic proteins in Reed-Sternberg cells. Cancer 41: 1793–1803, 1978
   Google Scholar
• Kadin ME, Holt L, Najfeld V: Malignant histiocytosis: Es-tablishment and characterisation of a permanent cell line. Blood 54\(Supp11):1738, 1979
   Google Scholar
• Poppema S: The diversity of immunohistological staining pattern of Sternberg-Reed cells. J Histochem Cytochem 28: 788–791, 1980
   PubMed Web of Science ®Google Scholar
• Poppema S, Bhan AK, Reinherz EL: In situ immunological characterisation of cellular constituents in lymph nodes and spleens involved by Hodgkin's disease. Blood 59:226–231, 1982
   PubMed Web of Science ®Google Scholar
• Halie MR, Thiadens J, Eibergin R, An den Brock AA: Hodg-kin's disease in the spleen. Investigation of Hodgkin's foci and areas of immune response. Virch Arch (Cell Pathol) 27:39–48, 1978
   PubMedGoogle Scholar
• Curran RC, Jones EL: Hodgkin's disease: An immuno-histochemical and histological study. J Pathol 125:39–51, 1978
   PubMed Web of Science ®Google Scholar
• Lukes RJ, Butler JJ, Hicks EB: Natural history of Hodgkin's disease as related to its pathologic picture. Cancer 19:317–344, 1966
   Web of Science ®Google Scholar
• Nicholas DS, Harris S, Wright DH: Lymphocyte predomi-nance Hodgkin's disease—an immunohistochemical study. Histopathology 16:157–165, 1990
   PubMed Web of Science ®Google Scholar
• Bishop PW, Harris M, Smith AP, Elsam KJ: Immunopheno-typic study of lymphocyte-predominance Hodgkin's disease. Histopathology 18:19–24, 1991
   PubMed Web of Science ®Google Scholar
• Kant JA, Hubbard SM, Longo DL: The pathologic and clini-cal heterogeneity of lymphocyte-depleted Hodgkin's disease. J Clin Oncol 4:284–294, 1986
   PubMed Web of Science ®Google Scholar
• Schmid C, Pan L, Diss T, Isaacson PG: Expression of B-cell antigens by Hodgkin's and Reed-Sternberg cells. Am J Pathol 139:701–707, 1991
   PubMed Web of Science ®Google Scholar
• Zukerberg LR, Collins AB, Ferry JA, Harris NL: Coexpres-sion of CD 15 and CD 20 by Reed-Sternberg cells in Hodg-kin's disease. Am J Pathol 139:475–483, 1991
   PubMed Web of Science ®Google Scholar
• Sundeen J, Lipford E, Uppenkamp M etal: Rearranged anti-gen receptor g.enes ifl Hodgkin's disease. Blood 70: 96–103, 1987
   PubMed Web of Science ®Google Scholar
• Stetler-Stevenson M, Crush-Stanton S, Cossman J: Involve-ment of the bc1-2 gene Hodgkin's disease. J Natl Cancer Inst 82: 855–858, 1990
   PubMed Web of Science ®Google Scholar